CRVO 25 year old man - Factor V Leiden Heterozygous
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 54820/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 43020/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 48420/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 41720/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 47420/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 43520/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 51920/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 43720/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 43520/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 42620/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 42620/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 41920/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 43520/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 43820/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 45920/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 42820/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 41920/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 46920/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 41320/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 39320/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 41420/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 45120/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 44620/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 48220/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 41520/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 hinnangut)
|
|
|
|
|
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy